Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A28036 | 16633331 | Panminerva Med | The metabolic syndrome and nonalcoholic fatty liver disease. | 2006 | Details |
| A28037 | 16630771 | Clin Gastroenterol Hepatol | A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. | 2006 | Details |
| A28038 | 16628637 | Hepatology | Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. | 2006 | Details |
| A28039 | 16624332 | Life Sci | High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. | 2006 | Details |
| A28041 | 16618517 | J Hepatol | Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. | 2006 | Details |
| A28044 | 16610015 | World J Gastroenterol | Treatment of nonalcoholic fatty liver disease. | 2006 | Details |
| A28047 | 16603025 | Clin Sci (Lond) | Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. | 2006 | Details |
| A28049 | 16595594 | J Clin Endocrinol Metab | Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. | 2006 | Details |
| A28051 | 28286458 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. | 2006 | Details |
| A28052 | 19858588 | Saudi J Gastroenterol | The role of leptin in non-alcoholic fatty liver disease. | 2009 | Details |
| A28053 | 16565603 | Korean J Hepatol | [Insulin resistance in non-alcoholic fatty liver disease]. | 2006 | Details |
| A28055 | 16557185 | Minerva Gastroenterol Dietol | Non-alcoholic fatty liver disease and hepatitis C infection. | 2006 | Details |
| A28056 | 16553034 | J Endocrinol Invest | Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. | 2006 | Details |
| A28059 | 16540770 | J Clin Gastroenterol | Therapy of NAFLD: insulin sensitizing agents. | 2006 | Details |
| A28060 | 16540769 | J Clin Gastroenterol | Therapy of NAFLD: antioxidants and cytoprotective agents. | 2006 | Details |
| A28061 | 16540768 | J Clin Gastroenterol | The epidemiology of nonalcoholic fatty liver disease in adults. | 2006 | Details |
| A28062 | 16540766 | J Clin Gastroenterol | Weight loss as a treatment for nonalcoholic fatty liver disease. | 2006 | Details |
| A28064 | 16540764 | J Clin Gastroenterol | Genetic influences in nonalcoholic fatty liver disease. | 2006 | Details |
| A28065 | 16540762 | J Clin Gastroenterol | Pathophysiology of nonalcoholic steatohepatitis. | 2006 | Details |
| A28071 | 16521351 | Clin Med (Lond) | Non-alcoholic fatty liver disease: current concepts and management strategies. | 2007 | Details |
| A28074 | 16506276 | Diabetes Metab Res Rev | Diabetes in chronic liver disease: from old concepts to new evidence. | 2006 | Details |
| A28077 | 16503761 | Expert Opin Investig Drugs | Recent findings concerning thiazolidinediones in the treatment of diabetes. | 2006 | Details |
| A28079 | 16672828 | J Clin Gastroenterol | Therapy of NAFLD: Insulin Sensitizing Agents. | 2006 | Details |
| A28080 | 16672820 | J Clin Gastroenterol | Pathophysiology of Nonalcoholic Steatohepatitis. | 2006 | Details |
| A28081 | 16496750 | Recenti Prog Med | [Steatosis and hepatitis C]. | 2005 | Details |
| A28084 | 16489632 | World J Gastroenterol | Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer? | 2006 | Details |
| A28085 | 16487446 | Clin Endocrinol (Oxf) | Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. | 2006 | Details |
| A28086 | 16485039 | J Clin Invest | Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. | 2006 | Details |
| A28092 | 16454845 | Am J Gastroenterol | Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. | 2006 | Details |
| A28093 | 16452829 | Keio J Med | Fat paradox in liver disease. | 2005 | Details |
| A28094 | 16448452 | Liver Int | Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A28095 | 16447287 | Hepatology | Nonalcoholic fatty liver disease: from steatosis to cirrhosis. | 2006 | Details |
| A28096 | 16439872 | AIDS | Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients. | 2006 | Details |
| A28097 | 16436109 | Int J Exp Pathol | Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. | 2006 | Details |
| A28098 | 16432495 | Ann Hepatol | Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City. | 2006 | Details |
| A28102 | 16420506 | Liver Int | Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD. | 2006 | Details |
| A28105 | 16416185 | Dig Dis Sci | Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A28106 | 16412031 | Chin J Dig Dis | Pathogenesis of nonalcoholic steatohepatitis (NASH). | 2006 | Details |
| A28107 | 16408478 | Nihon Koshu Eisei Zasshi | Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease. | 2005 | Details |
| A28110 | 16394799 | Eur J Gastroenterol Hepatol | Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. | 2006 | Details |
| A28111 | 16394091 | J Clin Endocrinol Metab | Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. | 2006 | Details |
| A28112 | 16393299 | Aliment Pharmacol Ther | Review article: Drug therapy for non-alcoholic fatty liver disease. | 2006 | Details |
| A28114 | 16385259 | J Pediatr Gastroenterol Nutr | Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. | 2006 | Details |
| A28115 | 16385233 | Alcohol Clin Exp Res | Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. | 2005 | Details |
| A28118 | 16376797 | Clin Liver Dis | Nonalcoholic fatty liver disease in children. | 2006 | Details |
| A28120 | 16374859 | Hepatology | Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. | 2006 | Details |
| A28121 | 16374858 | Hepatology | JNK1 but not JNK2 promotes the development of steatohepatitis in mice. | 2006 | Details |
| A28126 | 16356442 | J Pediatr | Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. | 2005 | Details |
| A28127 | 16355018 | Am J Med Sci | Nonalcoholic steatohepatitis and the metabolic syndrome. | 2005 | Details |
| A28134 | 16293559 | Scand J Gastroenterol | Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. | 2005 | Details |
| A28136 | 16284427 | Endocr J | Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. | 2005 | Details |
| A28140 | 16275057 | Hepatol Res | Clinical and pathological features of non-alcoholic steatohepatitis. | 2005 | Details |
| A28142 | 16270401 | World J Gastroenterol | Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? | 2005 | Details |
| A28144 | 16268963 | Aliment Pharmacol Ther | Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones. | 2005 | Details |
| A28145 | 16265156 | Nat Clin Pract Gastroenterol Hepatol | Treatment strategies in nonalcoholic fatty liver disease. | 2005 | Details |
| A28146 | 16265100 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. | 2005 | Details |
| A28156 | 16250043 | Hepatology | Insulin resistance: a metabolic pathway to chronic liver disease. | 2005 | Details |
| A28157 | 16249437 | Diabetes | Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. | 2005 | Details |
| A28159 | 16247633 | Internist (Berl) | [Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis]. | 2005 | Details |
| A28162 | 16242203 | Diabetes Res Clin Pract | Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease. | 2005 | Details |
| A28165 | 16231594 | Eur Rev Med Pharmacol Sci | The treatment of NAFLD. | 2006 | Details |
| A28166 | 16231592 | Eur Rev Med Pharmacol Sci | Steatosis and hepatocellular carcinoma risk. | 2006 | Details |
| A28168 | 16231589 | Eur Rev Med Pharmacol Sci | The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. | 2006 | Details |
| A28169 | 16231588 | Eur Rev Med Pharmacol Sci | Hepatic steatosis and vascular disease. | 2006 | Details |
| A28170 | 16231587 | Eur Rev Med Pharmacol Sci | Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH). | 2006 | Details |
| A28171 | 16231586 | Eur Rev Med Pharmacol Sci | Nonalcoholic fatty liver disease: defining a common problem. | 2006 | Details |
| A28173 | 16226488 | Hepatol Res | Epidemiological aspects of obesity and NASH/NAFLD in Japan. | 2005 | Details |
| A28175 | 16225477 | Aliment Pharmacol Ther | Review article: hepatic steatosis and insulin resistance. | 2005 | Details |
| A28176 | 16225476 | Aliment Pharmacol Ther | Iron and insulin resistance. | 2005 | Details |
| A28177 | 16225473 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications. | 2005 | Details |
| A28178 | 16225472 | Aliment Pharmacol Ther | Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. | 2005 | Details |
| A28179 | 16225470 | Aliment Pharmacol Ther | Review article: the treatment of fatty liver disease associated with the metabolic syndrome. | 2005 | Details |
| A28180 | 16225469 | Aliment Pharmacol Ther | Review article: the metabolic syndrome and non-alcoholic fatty liver disease. | 2005 | Details |
| A28183 | 16212005 | Rev Med Suisse | [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management]. | 2005 | Details |
| A28184 | 16212004 | Rev Med Suisse | [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms]. | 2005 | Details |
| A28188 | 16202646 | Hepatol Res | Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH. | 2005 | Details |
| A28190 | 16198624 | Hepatol Res | Lessons from animal models of NASH. | 2005 | Details |
| A28191 | 16198623 | Hepatol Res | The role of leptin in progression of non-alcoholic fatty liver disease. | 2005 | Details |
| A28193 | 16198620 | Hepatol Res | Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). | 2005 | Details |
| A28194 | 16197788 | Obes Surg | Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. | 2005 | Details |
| A28196 | 16179269 | Ann Med | Is liver disease a threat to patients with metabolic disorders? | 2005 | Details |
| A28200 | 16168516 | J Hepatol | Hepatic steatosis and insulin resistance: does etiology make a difference? | 2005 | Details |
| A28203 | 16150132 | J Hum Nutr Diet | Body mass index and waist circumference in non-alcoholic fatty liver disease. | 2005 | Details |
| A28208 | 16139921 | J Hepatol | Adiponectin and its receptors in patients with chronic hepatitis C. | 2005 | Details |
| A28211 | 16120375 | Mitochondrion | Mitochondrial injury in the pathogenesis of antiretroviral-induced hepatic steatosis and lactic acidemia. | 2004 | Details |
| A28216 | 16108837 | Diabet Med | Recent concepts in non-alcoholic fatty liver disease. | 2005 | Details |
| A28217 | 16105135 | J Gastroenterol Hepatol | Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. | 2005 | Details |
| A28219 | 16095853 | J Ethnopharmacol | Euonymus alatus prevents the hyperglycemia and hyperlipidemia induced by high-fat diet in ICR mice. | 2005 | Details |
| A28221 | 16092984 | Zhonghua Gan Zang Bing Za Zhi | [A study of the changes of hepatic gene expression in the process of nonalcoholic fatty liver disease development using U230A oligonucleotide microarray]. | 2005 | Details |
| A28222 | 16088092 | Ann Nutr Metab | Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. | 2005 | Details |
| A28226 | 16048564 | J Gastroenterol Hepatol | Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. | 2005 | Details |
| A28233 | 16003133 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum. | 2005 | Details |
| A28234 | 16003131 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and insulin resistance. | 2005 | Details |
| A28238 | 15990709 | Minerva Gastroenterol Dietol | [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study]. | 2005 | Details |
| A28243 | 15981216 | Hepatology | Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. | 2005 | Details |
| A28246 | 15970496 | Front Biosci | Non-alcoholic fatty liver disease (NAFLD) in children. | 2005 | Details |
| A28247 | 15970480 | Front Biosci | Uncoupling protein-2 and non-alcoholic fatty liver disease. | 2005 | Details |
| A28248 | 15966506 | J Endocrinol Invest | Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. | 2005 | Details |
| A28249 | 15953863 | J Korean Med Sci | Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease. | 2005 | Details |
| A28252 | 15948897 | Eur J Clin Invest | Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. | 2005 | Details |